ReviewCurrent hematologic malignancy reports2014

Ruxolitinib: long-term management of patients with myelofibrosis and future directions in the treatment of myeloproliferative neoplasms.

A Yacoub et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.